Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
1-year Mortality
9%
95% Confidence Interval
20%
Aborted Cardiac Arrest
11%
Acute Decompensated Heart Failure
11%
All-cause Mortality
10%
Cardiac Events
35%
Cardiac Resynchronization
11%
Cardiac Resynchronization Therapy
97%
Cardioverter-defibrillator Implantation
74%
Clinical Outcomes
21%
Congenital Long QT Syndrome
11%
Coronary Revascularization
9%
Genotype
12%
Hazard Ratio
50%
Heart Failure
24%
Heart Failure Events
13%
Heart Failure Patients
9%
Implantable Cardioverter-defibrillator
35%
Implantable Cardioverter-defibrillator Shock
16%
Ischemic Cardiomyopathy
18%
Israeli
15%
Left Bundle Branch Block
22%
Left Ventricular Dysfunction
13%
Life-threatening
38%
Long QT Syndrome
44%
Long QT Syndrome Type 1
9%
MADIT-CRT
22%
Mild Heart Failure
12%
Mildly Symptomatic
12%
Multivariate Analysis
16%
Mutation Specific
14%
Nonischemic Cardiomyopathy
12%
Patient Outcomes
9%
Patients with Heart Failure
12%
Primary Prevention
9%
Risk Factors
19%
Risk Reduction
9%
Risk Stratification
12%
Severe Aortic Stenosis
15%
Statins
9%
Sudden Cardiac Death
19%
Symptomatic Heart Failure
12%
Syncope
20%
Temporal Trends
11%
Three-dimensional Conformal Radiotherapy
46%
Transcatheter Aortic Valve Implantation
25%
Transcatheter Aortic Valve Replacement
21%
Ventricular Arrhythmia
37%
Ventricular Tachycardia/fibrillation
14%
Wearable Cardioverter Defibrillator
9%
Medicine and Dentistry
Acute Coronary Syndrome
7%
Adverse Event
7%
All Cause Mortality
6%
Aortic Stenosis
23%
Aortic Valve
13%
Apoplexy
9%
Atrial Fibrillation
20%
Cardiac Dysrhythmia
9%
Cardiac Resynchronization Therapy
100%
Cardiovascular System
8%
Congenital Long-QT Syndrome
10%
Congestive Heart Failure
71%
Defibrillator
74%
Diabetes Mellitus
11%
Diseases
8%
Faintness
20%
Genetics
7%
Hazard Ratio
40%
Heart Arrest
8%
Heart Death
14%
Heart Left Ventricle Ejection Fraction
14%
Heart Left Ventricle Failure
10%
Heart Muscle Conduction Disturbance
10%
Heart Muscle Revascularization
9%
Hemodynamic
14%
Implantable Automatic Defibrillator
55%
Ischemic Cardiomyopathy
16%
Left Bundle Branch Block
21%
Long QT Syndrome
31%
Long QT Syndrome 1
10%
Long QT Syndrome 2
8%
Long Term Survival
8%
Long-Term Outcome
14%
Multicenter Automatic Defibrillator Implantation Trial
52%
Multivariate Analysis
13%
Nonischemic Cardiomyopathy
8%
Pacemaker
10%
Pacemaker Implantation
7%
Paravalvular Leak
7%
Pathophysiology
6%
Percutaneous Aortic Valve Replacement
57%
Permanent Pacemaker
7%
Primary Prevention
12%
Recurrent Disease
6%
Risk Stratification
12%
Sinus Rhythm
6%
Sudden Cardiac Death
21%
Ventricular Fibrillation
16%
Ventricular Tachycardia
40%
Warfarin
6%
